ProQR Therapeutics N.V. (PRQR) PT Raised to $34 at Citi
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $1.65 -3.51%
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on ProQR Therapeutics N.V. (NASDAQ: PRQR) to $34.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Paychex (PAYX) PT Lowered to $105 at TD Cowen
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR140 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
